These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29580980)

  • 1. Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners.
    Xu L; Wu Z; Tan S; Wang Z; Lin Q; Li X; Song X; Liu Y; Song Y; Zhang J; Peng J; Gao L; Gong Y; Liang X; Zuo X; Ma C
    Antiviral Res; 2018 May; 153():114-123. PubMed ID: 29580980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection.
    Zhang Y; Mao R; Yan R; Cai D; Zhang Y; Zhu H; Kang Y; Liu H; Wang J; Qin Y; Huang Y; Guo H; Zhang J
    PLoS One; 2014; 9(10):e110442. PubMed ID: 25337821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
    Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
    J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
    Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J
    Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription.
    Yuan Y; Zhao K; Yao Y; Liu C; Chen Y; Li J; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Wu C; Chen X
    Antiviral Res; 2019 Dec; 172():104619. PubMed ID: 31600533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
    J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid X Receptor α-Dependent HBV Minichromosome Remodeling and Viral Replication.
    Zhang Y; He S; Guo JJ; Peng H; Fan JH; Li QL
    Ann Hepatol; 2017; 16(4):501-509. PubMed ID: 28611266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
    Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
    Kim ES; Zhou J; Zhang H; Marchetti A; van de Klundert M; Cai D; Yu X; Mitra B; Liu Y; Wang M; Protzer U; Guo H
    PLoS Pathog; 2022 Jun; 18(6):e1010576. PubMed ID: 35679251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
    Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L
    PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.
    Malmström S; Larsson SB; Hannoun C; Lindh M
    PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators.
    Cai D; Wang X; Yan R; Mao R; Liu Y; Ji C; Cuconati A; Guo H
    Antiviral Res; 2016 Aug; 132():26-37. PubMed ID: 27185623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
    Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
    Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status.
    Koumbi L; Pollicino T; Raimondo G; Stampoulis D; Khakoo S; Karayiannis P
    Virus Res; 2016 Jul; 220():150-60. PubMed ID: 27132039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.
    Kim JW; Lee SH; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH
    Intervirology; 2011; 54(6):316-25. PubMed ID: 21242658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.
    Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M
    Virol J; 2015 Dec; 12():213. PubMed ID: 26645241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription.
    Yu X; Long Q; Shen S; Liu Z; Chandran J; Zhang J; Ding H; Zhang H; Cai D; Kim ES; Huang Y; Guo H
    Antiviral Res; 2023 Mar; 211():105552. PubMed ID: 36737008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
    Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
    Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.